Exosome Diagnostic Market worth $2.9 billion by 2030, growing at a CAGR of 29.4%

Allied Market Research published a report, titled, "the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030″.

Alarming rise in prevalence of cancer & infectious disease and increase in number of approval for exosome therapeutics & diagnostics are expected to notably contribute toward the growth of the global exosome diagnostic & therapeutic market during the forecast period.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/1723

Covid-19 scenario-

Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.

This trend is pretty likely to continue till the pandemic is completely over.

Major Factors Driving the Growth of Exosome Diagnostic and Therapeutic Market:

1. Rising Prevalence of Chronic Diseases:

The increasing prevalence of chronic diseases such as cancer, Alzheimer's disease, Parkinson's disease, and autoimmune disorders is a major driver of the market.

Exosomes have shown promising potential for early diagnosis and personalized treatment of these diseases.

2. Technological Advancements:

Significant advancements in exosome isolation, characterization, and engineering are enabling the development of more accurate and reliable diagnostic tests and targeted therapeutic strategies.

These advancements include:

Development of microfluidic devices for efficient exosome isolation.

Advancements in mass spectrometry and next-generation sequencing for exosome identification and characterization.

Engineering exosomes for targeted drug delivery and therapeutic applications.

3. Growing Recognition of Exosomes as Biomarkers:

Exosomes are increasingly recognized as valuable biomarkers for disease diagnosis, prognosis, and monitoring.

Their unique properties, such as stability, cell-type specificity, and cargo content, make them ideal candidates for non-invasive and specific disease detection.

Market Segmentation:

By Application:

Diagnostic
Therapeutic

By Product:

Instrument
Reagent
Software

By End User:

Cancer Institute
Hospital
Diagnostic Center
Others

By Region:

North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Rest of Asia-Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Request for Customization:

https://www.alliedmarketresearch.com/request-for-customization/1723

North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.

Key players in the industry:

Exosome Diagnostics Inc.
NanoSomix Inc.
Thermo Fisher Scientific Inc.
Malvern Instruments Ltd.
System Biosciences Inc.
NX Pharmagen
Aethlon Medical, Inc.
Sistemic Inc.

Trending Reports in Healthcare Industry:

Arthroscopy Devices Market: https://www.alliedmarketresearch.com/arthroscopy-devices-market

Pharmacy Automation System Market: https://www.alliedmarketresearch.com/pharmacy-automation-systems-market

Transdermal Drug Delivery Systems Market: https://www.alliedmarketresearch.com/transdermal-drug-delivery-systems-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.